It is reported that the uPAR expression was elevated in AML patients than healthy people, that primary AML patients with high expression levels of uPAR often receive a poor prognosis and that uPA can be used as an important prognostic indicator for patients with AML [22]. The gene discussed is PLAU; the disease is acute myeloid leukemia.